[Solitary bone plasmocytoma: treatment and outcome features].
Identifieur interne : 000067 ( PubMed/Checkpoint ); précédent : 000066; suivant : 000068[Solitary bone plasmocytoma: treatment and outcome features].
Auteurs : L. Kochbati [Tunisie] ; N Kédidi Ben Romdhane ; K. Mrad ; C. Nasr ; D E Ben Salah ; K. Ben Romdhane ; M. MaalejSource :
- Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [ 1278-3218 ] ; 2004.
Descripteurs français
- KwdFr :
- Adulte, Adulte d'âge moyen, Association thérapeutique, Biopsie, Facteurs temps, Femelle, Humains, Laminectomie, Myélome multiple (étiologie), Mâle, Plasmocytome (), Plasmocytome (anatomopathologie), Plasmocytome (radiothérapie), Plasmocytome (traitement médicamenteux), Radio-isotopes du cobalt (usage thérapeutique), Radiothérapie de haute énergie, Résultat thérapeutique, Tibia (anatomopathologie), Tumeurs du rachis (), Tumeurs du rachis (anatomopathologie), Tumeurs du rachis (radiothérapie), Tumeurs du rachis (traitement médicamenteux), Tumeurs osseuses (), Tumeurs osseuses (anatomopathologie), Tumeurs osseuses (radiothérapie), Tumeurs osseuses (traitement médicamenteux), Télégammathérapie, Études de suivi, Études rétrospectives.
- MESH :
- anatomopathologie : Plasmocytome, Tibia, Tumeurs du rachis, Tumeurs osseuses.
- radiothérapie : Plasmocytome, Tumeurs du rachis, Tumeurs osseuses.
- traitement médicamenteux : Plasmocytome, Tumeurs du rachis, Tumeurs osseuses.
- usage thérapeutique : Radio-isotopes du cobalt.
- étiologie : Myélome multiple.
- Adulte, Adulte d'âge moyen, Association thérapeutique, Biopsie, Facteurs temps, Femelle, Humains, Laminectomie, Mâle, Plasmocytome, Radiothérapie de haute énergie, Résultat thérapeutique, Tumeurs du rachis, Tumeurs osseuses, Télégammathérapie, Études de suivi, Études rétrospectives.
English descriptors
- KwdEn :
- Adult, Biopsy, Bone Neoplasms (drug therapy), Bone Neoplasms (pathology), Bone Neoplasms (radiotherapy), Bone Neoplasms (surgery), Cobalt Radioisotopes (therapeutic use), Combined Modality Therapy, Female, Follow-Up Studies, Humans, Laminectomy, Male, Middle Aged, Multiple Myeloma (etiology), Plasmacytoma (drug therapy), Plasmacytoma (pathology), Plasmacytoma (radiotherapy), Plasmacytoma (surgery), Radioisotope Teletherapy, Radiotherapy, High-Energy, Retrospective Studies, Spinal Neoplasms (drug therapy), Spinal Neoplasms (pathology), Spinal Neoplasms (radiotherapy), Spinal Neoplasms (surgery), Tibia (pathology), Time Factors, Treatment Outcome.
- MESH :
- chemical , therapeutic use : Cobalt Radioisotopes.
- drug therapy : Bone Neoplasms, Plasmacytoma, Spinal Neoplasms.
- etiology : Multiple Myeloma.
- pathology : Bone Neoplasms, Plasmacytoma, Spinal Neoplasms, Tibia.
- radiotherapy : Bone Neoplasms, Plasmacytoma, Spinal Neoplasms.
- surgery : Bone Neoplasms, Plasmacytoma, Spinal Neoplasms.
- Adult, Biopsy, Combined Modality Therapy, Female, Follow-Up Studies, Humans, Laminectomy, Male, Middle Aged, Radioisotope Teletherapy, Radiotherapy, High-Energy, Retrospective Studies, Time Factors, Treatment Outcome.
Abstract
- To describe natural history of solitary bone plasmocytomas (SBO) after treatment.
DOI: 10.1016/j.canrad.2003.11.003
PubMed: 15063873
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
pubmed:15063873Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Solitary bone plasmocytoma: treatment and outcome features].</title>
<author><name sortKey="Kochbati, L" sort="Kochbati, L" uniqKey="Kochbati L" first="L" last="Kochbati">L. Kochbati</name>
<affiliation wicri:level="1"><nlm:affiliation>Service de radiothérapie carcinologique, institut Salah-Azaïz, Bab-Saadoun, 1006 Tunis, Tunisie. lofti.kochbati@rns.tn</nlm:affiliation>
<country xml:lang="fr">Tunisie</country>
<wicri:regionArea>Service de radiothérapie carcinologique, institut Salah-Azaïz, Bab-Saadoun, 1006 Tunis</wicri:regionArea>
<placeName><settlement type="city">Tunis</settlement>
<region nuts="2">Gouvernorat de Tunis</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ben Romdhane, N Kedidi" sort="Ben Romdhane, N Kedidi" uniqKey="Ben Romdhane N" first="N Kédidi" last="Ben Romdhane">N Kédidi Ben Romdhane</name>
</author>
<author><name sortKey="Mrad, K" sort="Mrad, K" uniqKey="Mrad K" first="K" last="Mrad">K. Mrad</name>
</author>
<author><name sortKey="Nasr, C" sort="Nasr, C" uniqKey="Nasr C" first="C" last="Nasr">C. Nasr</name>
</author>
<author><name sortKey="Ben Salah, D E" sort="Ben Salah, D E" uniqKey="Ben Salah D" first="D E" last="Ben Salah">D E Ben Salah</name>
</author>
<author><name sortKey="Ben Romdhane, K" sort="Ben Romdhane, K" uniqKey="Ben Romdhane K" first="K" last="Ben Romdhane">K. Ben Romdhane</name>
</author>
<author><name sortKey="Maalej, M" sort="Maalej, M" uniqKey="Maalej M" first="M" last="Maalej">M. Maalej</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2004">2004</date>
<idno type="RBID">pubmed:15063873</idno>
<idno type="pmid">15063873</idno>
<idno type="doi">10.1016/j.canrad.2003.11.003</idno>
<idno type="wicri:Area/PubMed/Corpus">000068</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000068</idno>
<idno type="wicri:Area/PubMed/Curation">000068</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000068</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000068</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000068</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">[Solitary bone plasmocytoma: treatment and outcome features].</title>
<author><name sortKey="Kochbati, L" sort="Kochbati, L" uniqKey="Kochbati L" first="L" last="Kochbati">L. Kochbati</name>
<affiliation wicri:level="1"><nlm:affiliation>Service de radiothérapie carcinologique, institut Salah-Azaïz, Bab-Saadoun, 1006 Tunis, Tunisie. lofti.kochbati@rns.tn</nlm:affiliation>
<country xml:lang="fr">Tunisie</country>
<wicri:regionArea>Service de radiothérapie carcinologique, institut Salah-Azaïz, Bab-Saadoun, 1006 Tunis</wicri:regionArea>
<placeName><settlement type="city">Tunis</settlement>
<region nuts="2">Gouvernorat de Tunis</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Ben Romdhane, N Kedidi" sort="Ben Romdhane, N Kedidi" uniqKey="Ben Romdhane N" first="N Kédidi" last="Ben Romdhane">N Kédidi Ben Romdhane</name>
</author>
<author><name sortKey="Mrad, K" sort="Mrad, K" uniqKey="Mrad K" first="K" last="Mrad">K. Mrad</name>
</author>
<author><name sortKey="Nasr, C" sort="Nasr, C" uniqKey="Nasr C" first="C" last="Nasr">C. Nasr</name>
</author>
<author><name sortKey="Ben Salah, D E" sort="Ben Salah, D E" uniqKey="Ben Salah D" first="D E" last="Ben Salah">D E Ben Salah</name>
</author>
<author><name sortKey="Ben Romdhane, K" sort="Ben Romdhane, K" uniqKey="Ben Romdhane K" first="K" last="Ben Romdhane">K. Ben Romdhane</name>
</author>
<author><name sortKey="Maalej, M" sort="Maalej, M" uniqKey="Maalej M" first="M" last="Maalej">M. Maalej</name>
</author>
</analytic>
<series><title level="j">Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique</title>
<idno type="ISSN">1278-3218</idno>
<imprint><date when="2004" type="published">2004</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Biopsy</term>
<term>Bone Neoplasms (drug therapy)</term>
<term>Bone Neoplasms (pathology)</term>
<term>Bone Neoplasms (radiotherapy)</term>
<term>Bone Neoplasms (surgery)</term>
<term>Cobalt Radioisotopes (therapeutic use)</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Laminectomy</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Multiple Myeloma (etiology)</term>
<term>Plasmacytoma (drug therapy)</term>
<term>Plasmacytoma (pathology)</term>
<term>Plasmacytoma (radiotherapy)</term>
<term>Plasmacytoma (surgery)</term>
<term>Radioisotope Teletherapy</term>
<term>Radiotherapy, High-Energy</term>
<term>Retrospective Studies</term>
<term>Spinal Neoplasms (drug therapy)</term>
<term>Spinal Neoplasms (pathology)</term>
<term>Spinal Neoplasms (radiotherapy)</term>
<term>Spinal Neoplasms (surgery)</term>
<term>Tibia (pathology)</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Association thérapeutique</term>
<term>Biopsie</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Laminectomie</term>
<term>Myélome multiple (étiologie)</term>
<term>Mâle</term>
<term>Plasmocytome ()</term>
<term>Plasmocytome (anatomopathologie)</term>
<term>Plasmocytome (radiothérapie)</term>
<term>Plasmocytome (traitement médicamenteux)</term>
<term>Radio-isotopes du cobalt (usage thérapeutique)</term>
<term>Radiothérapie de haute énergie</term>
<term>Résultat thérapeutique</term>
<term>Tibia (anatomopathologie)</term>
<term>Tumeurs du rachis ()</term>
<term>Tumeurs du rachis (anatomopathologie)</term>
<term>Tumeurs du rachis (radiothérapie)</term>
<term>Tumeurs du rachis (traitement médicamenteux)</term>
<term>Tumeurs osseuses ()</term>
<term>Tumeurs osseuses (anatomopathologie)</term>
<term>Tumeurs osseuses (radiothérapie)</term>
<term>Tumeurs osseuses (traitement médicamenteux)</term>
<term>Télégammathérapie</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Cobalt Radioisotopes</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Plasmocytome</term>
<term>Tibia</term>
<term>Tumeurs du rachis</term>
<term>Tumeurs osseuses</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Bone Neoplasms</term>
<term>Plasmacytoma</term>
<term>Spinal Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Multiple Myeloma</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Bone Neoplasms</term>
<term>Plasmacytoma</term>
<term>Spinal Neoplasms</term>
<term>Tibia</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Bone Neoplasms</term>
<term>Plasmacytoma</term>
<term>Spinal Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Plasmocytome</term>
<term>Tumeurs du rachis</term>
<term>Tumeurs osseuses</term>
</keywords>
<keywords scheme="MESH" qualifier="surgery" xml:lang="en"><term>Bone Neoplasms</term>
<term>Plasmacytoma</term>
<term>Spinal Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Plasmocytome</term>
<term>Tumeurs du rachis</term>
<term>Tumeurs osseuses</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Radio-isotopes du cobalt</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Myélome multiple</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Biopsy</term>
<term>Combined Modality Therapy</term>
<term>Female</term>
<term>Follow-Up Studies</term>
<term>Humans</term>
<term>Laminectomy</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Radioisotope Teletherapy</term>
<term>Radiotherapy, High-Energy</term>
<term>Retrospective Studies</term>
<term>Time Factors</term>
<term>Treatment Outcome</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Association thérapeutique</term>
<term>Biopsie</term>
<term>Facteurs temps</term>
<term>Femelle</term>
<term>Humains</term>
<term>Laminectomie</term>
<term>Mâle</term>
<term>Plasmocytome</term>
<term>Radiothérapie de haute énergie</term>
<term>Résultat thérapeutique</term>
<term>Tumeurs du rachis</term>
<term>Tumeurs osseuses</term>
<term>Télégammathérapie</term>
<term>Études de suivi</term>
<term>Études rétrospectives</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">- To describe natural history of solitary bone plasmocytomas (SBO) after treatment.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">15063873</PMID>
<DateCreated><Year>2004</Year>
<Month>4</Month>
<Day>5</Day>
</DateCreated>
<DateCompleted><Year>2004</Year>
<Month>05</Month>
<Day>20</Day>
</DateCompleted>
<DateRevised><Year>2006</Year>
<Month>11</Month>
<Day>15</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">1278-3218</ISSN>
<JournalIssue CitedMedium="Print"><Volume>8</Volume>
<Issue>2</Issue>
<PubDate><Year>2004</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique</Title>
<ISOAbbreviation>Cancer Radiother</ISOAbbreviation>
</Journal>
<ArticleTitle>[Solitary bone plasmocytoma: treatment and outcome features].</ArticleTitle>
<Pagination><MedlinePgn>70-4</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">- To describe natural history of solitary bone plasmocytomas (SBO) after treatment.</AbstractText>
<AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">- Between 1975 and 1998, we retrospectively identified 13 patients with SBO treated in the department of radiotherapy at Salah-Azaïz institute of Tunis. To be included in this study, three criteria were needed: histologic confirmation and only one bone lesion without medullary infiltration (or less than 10%). Mean age was 43 years (22-64) with sex-ratio of 3,3. Tumor sites were vertebra (6), flat bones (6) and tibia (1). Megavoltage radiotherapy was given to all patients, associated to surgery in eight cases (5 excisions and 3 laminectomies) and to chemotherapy in three.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">- With a mean follow-up of 63 months, two local failures were noted at 24 and 48 months. Two patients developed multifocal lesions and one patient had an extramedullary lesion. Multiple myeloma occurred in four patients (30%) after a median follow-up 3,5 years. Unfavorable outcome could not be predicted by age, gender or site of disease but by myeloma protein.</AbstractText>
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">- Radiotherapy is an effective local treatment for solitary bone plasmocytoma. Prospective studies are needed to better define predictive parameters of unfavourable outcome and indications of combined chemotherapy.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kochbati</LastName>
<ForeName>L</ForeName>
<Initials>L</Initials>
<AffiliationInfo><Affiliation>Service de radiothérapie carcinologique, institut Salah-Azaïz, Bab-Saadoun, 1006 Tunis, Tunisie. lofti.kochbati@rns.tn</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Ben Romdhane</LastName>
<ForeName>N Kédidi</ForeName>
<Initials>NK</Initials>
</Author>
<Author ValidYN="Y"><LastName>Mrad</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Nasr</LastName>
<ForeName>C</ForeName>
<Initials>C</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ben Salah</LastName>
<ForeName>D E</ForeName>
<Initials>DE</Initials>
</Author>
<Author ValidYN="Y"><LastName>Ben Romdhane</LastName>
<ForeName>K</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y"><LastName>Maalej</LastName>
<ForeName>M</ForeName>
<Initials>M</Initials>
</Author>
</AuthorList>
<Language>ENG</Language>
<Language>FRE</Language>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>France</Country>
<MedlineTA>Cancer Radiother</MedlineTA>
<NlmUniqueID>9711272</NlmUniqueID>
<ISSNLinking>1278-3218</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D003037">Cobalt Radioisotopes</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001706" MajorTopicYN="N">Biopsy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001859" MajorTopicYN="N">Bone Neoplasms</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003037" MajorTopicYN="N">Cobalt Radioisotopes</DescriptorName>
<QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003131" MajorTopicYN="N">Combined Modality Therapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007796" MajorTopicYN="N">Laminectomy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009101" MajorTopicYN="N">Multiple Myeloma</DescriptorName>
<QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D010954" MajorTopicYN="N">Plasmacytoma</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011867" MajorTopicYN="N">Radioisotope Teletherapy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011882" MajorTopicYN="N">Radiotherapy, High-Energy</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013125" MajorTopicYN="N">Spinal Neoplasms</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
<QualifierName UI="Q000532" MajorTopicYN="N">radiotherapy</QualifierName>
<QualifierName UI="Q000601" MajorTopicYN="N">surgery</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013977" MajorTopicYN="N">Tibia</DescriptorName>
<QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013997" MajorTopicYN="N">Time Factors</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2003</Year>
<Month>May</Month>
<Day>26</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2003</Year>
<Month>Oct</Month>
<Day>29</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2003</Year>
<Month>Nov</Month>
<Day>18</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2004</Year>
<Month>4</Month>
<Day>6</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2004</Year>
<Month>5</Month>
<Day>21</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2004</Year>
<Month>4</Month>
<Day>6</Day>
<Hour>5</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">15063873</ArticleId>
<ArticleId IdType="doi">10.1016/j.canrad.2003.11.003</ArticleId>
<ArticleId IdType="pii">S1278321803001380</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>Tunisie</li>
</country>
<region><li>Gouvernorat de Tunis</li>
</region>
<settlement><li>Tunis</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Ben Romdhane, K" sort="Ben Romdhane, K" uniqKey="Ben Romdhane K" first="K" last="Ben Romdhane">K. Ben Romdhane</name>
<name sortKey="Ben Romdhane, N Kedidi" sort="Ben Romdhane, N Kedidi" uniqKey="Ben Romdhane N" first="N Kédidi" last="Ben Romdhane">N Kédidi Ben Romdhane</name>
<name sortKey="Ben Salah, D E" sort="Ben Salah, D E" uniqKey="Ben Salah D" first="D E" last="Ben Salah">D E Ben Salah</name>
<name sortKey="Maalej, M" sort="Maalej, M" uniqKey="Maalej M" first="M" last="Maalej">M. Maalej</name>
<name sortKey="Mrad, K" sort="Mrad, K" uniqKey="Mrad K" first="K" last="Mrad">K. Mrad</name>
<name sortKey="Nasr, C" sort="Nasr, C" uniqKey="Nasr C" first="C" last="Nasr">C. Nasr</name>
</noCountry>
<country name="Tunisie"><region name="Gouvernorat de Tunis"><name sortKey="Kochbati, L" sort="Kochbati, L" uniqKey="Kochbati L" first="L" last="Kochbati">L. Kochbati</name>
</region>
</country>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/CobaltMaghrebV1/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000067 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000067 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Terre |area= CobaltMaghrebV1 |flux= PubMed |étape= Checkpoint |type= RBID |clé= pubmed:15063873 |texte= [Solitary bone plasmocytoma: treatment and outcome features]. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i -Sk "pubmed:15063873" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a CobaltMaghrebV1
![]() | This area was generated with Dilib version V0.6.32. | ![]() |